FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Daily Wear Soft Contact Lens To Reduce The Progression Of Myopia

PMA: P180035 · Supplement: S007 · Decision Mar 26, 2021
Classifications
1
FEI Numbers
5
Registration Numbers
5

Basic Information

Device Name
Daily Wear Soft Contact Lens To Reduce The Progression Of Myopia
Trade Name
MiSight 1 Day (omafilcon A) Soft (Hydrophilic) Contact Lenses for Daily Wear
PMA Number
P180035
Supplement Number
S007
Device Class
FDA Class 3
Product Code
QIT
Generic Name
Daily wear soft contact lens to reduce the progression of myopia
Medical Specialty
Unknown
Advisory Committee
Ophthalmic
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
March 26, 2021
Date Received
March 5, 2021
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Introduction of new reduced quality control sampling plan for lens dry process along with new inspection software.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QIT Daily Wear Soft Contact Lens To Reduce The Progression Of Myopia